FLOREtina 2015
International Congress
www.floretina.it
Florence (Italy)
10-13 December 2015
Organizers:
Stanislao Rizzo - Florence (Italy)
Carl Claes - Antwerpen (Belgium)
José García-Arumí - Barcelona (Spain)
Kourous A. Rezaei - Chicago (USA)
Ramin Tadayoni - Paris (France)
FLOREtina 2015 APP
Install the FLOREtina 2015 interactive mobile App to your smartphone and
portable devices to access all the Congress information you could need during
and after the Congress:
- See the overview of sessions, speakers and exhibitors;
- Create your own program for the event, including bookmarking the sessions
you wish to attend;
- Vote during plenary sessions;
- Receive real-time updates.
Download the FLOREtina App now to enhance your congress experience!
Dear Friends and Colleagues,
We are delighted to welcome you to Florence for the 1st edition of FLOREtina meeting on 10-13 December 2015.
The main topics include both medical and surgical retina diseases. Innovations in imaging, diagnostic techniques
and different treatment approaches will be the focus of the discussion. Scientific program comprises plenary
sessions with debates and panel discussions, delegates from all over the world will be involved in the meeting
with televoting system.
On Friday and Saturday morning, during live surgery from University Hospital of Florence, the surgeons will
show new surgical techniques, new machines as well as how to operate them to achieve the best results both in
routine and complicated retina surgery cases.
We are hoping for a truly international meeting without a local connotation. On the other hand Florence, which
is considered the birthplace of the Renaissance, the cradle of artists, scientists and inventors, represents an ideal
framework for an all over the world knowledge sharing.
Looking forward to welcoming you to Florence,
Download available on
or point the camera of your device on the image below
(requires an app to scan the QRCode)
Stanislao Rizzo
Carl Claes
José García-Arumí
Kourous A. Rezaei
Ramin Tadayoni
1
UNDER THE PATRONAGE OF:
COMMITTEES & FACULTY
ORGANIZERS
Stanislao Rizzo - Florence (Italy)
Carl Claes - Antwerpen (Belgium)
José García-Arumí - Barcelona (Spain)
Kourous A. Rezaei - Chicago (USA)
Ramin Tadayoni - Paris (France)
PROGRAM COMMITTEE
Fernando Arévalo, USA
Remzi Avci, Turkey
Francesco Bandello, Italy
Martín Charles, Argentina
Francesco Faraldi, Italy
André Gomes, Brazil
Virgilio Morales-Canton, Mexico
Manish Nagpal, India
Yuichiro Ogura, Japan
Ehab El Rayes, Egypt
Gianni Virgili, Italy
Young-Hee Yoon, South Korea
SURGEONS
Involved in Live Surgery
Pierre-Olivier Barale, France
Francesco Boscia, Italy
Antonio Jr. Capone, USA
Steve Charles, USA
David Chow, Canada
Carl Claes, Belgium
Michele Coppola, Italy
José García-Arumí, Spain
Carlos Mateo, Spain
Cesare Mariotti, Italy
Virgilio Morales-Canton, Mexico
Marco Mura, Saudi Arabia
Stanislao Rizzo, Italy
Tommaso Rossi, Italy
Ramin Tadayoni, France
SCIENTIFIC SECRETARIAT
Andrea Giorni, Italy
Alfonso Savastano, Italy
Tomaso Caporossi, Italy
Francesco Barca, Italy
2
INTERNATIONAL SPEAKERS
Carl C. Awh, USA
Pierre-Olivier Barale, France
Susan Bressler, USA
Antonio Jr. Capone, USA
Steve Charles, USA
David Chow, Canada
Borja Corcostegui, Spain
Lyndon Da Cruz, UK
Donald J. D’Amico, USA
Pravin U. Dugel, USA
Claus Eckardt, Germany
Marta S. Figueroa, Spain
Thomas Friberg, USA
Stratos V. Gotzaridis, Greece
Giuseppe Guarnaccia, Switzerland
Tarek Hassan, USA
Heinrich Heimann, UK
Allen C. Ho, USA
Suber Huang, USA
Mark Humayun, USA
Antonia Joussen, Germany
Kazuaki Kadonosono, Japan
Jean Francois Korobelnik, France
Baruch Kuppermann, USA
Anat Loewenstein, Israel
Robert MacLaren, UK
Stephanie Magazzeni, France
Carlos Mateo, Spain
Joseph Moisseiev, Israel
Marco Mura, Saudi Arabia
Fanny Nerinckx, Belgium
Kirk Packo, USA
Michel Paques, France
Gisbert Richard, Germany
Gabor B. Scharioth, Germany
Stephen G. Schwartz, USA
Steven D. Schwartz, USA
Paulo Stanga, UK
Patricia Udaondo, Spain
George Williams, USA
Thomas Wolfensberger, Switzerland
David Wong, China
Marco Zarbin, USA
Sandrine Zweifel, Switzerland
NATIONAL SPEAKERS
Paolo Arpa, Italy
Claudio Azzolini, Italy
Maurizio Battaglia Parodi, Italy
Giorgio Beltrame, Italy
Francesco Boscia, Italy
Paolo Carpineto, Italy
Marzio Chizzolini, Italy
Michele Coppola, Italy
Stefano De Cillà, Italy
Pasquale De Rosa, Italy
Pier Luigi Esposti, Italy
Bruno Falcomatà, Italy
Luigi Fontana, Italy
Cesare Forlini, Italy
Fabrizio Giansanti, Italy
Alfonso Giovannini, Italy
Paolo Lanzetta, Italy
Guido Lesnoni, Italy
Cesare Mariotti, Italy
Cinzia Mazzini, Italy
Ugo Menchini, Italy
Rita Mencucci, Italy
Francesco Saverio Mennini, Italy
Andrea Mercanti, Italy
Edoardo Midena, Italy
Piergiorgio Neri, Italy
Claudio Panico, Italy
Francesco Parmeggiani, Italy
Mariacristina Parravano, Italy
Fabio Patelli, Italy
Alfredo Pece, Italy
Grazia Pertile, Italy
Vittorio Picardo, Italy
Stefano Piermarocchi, Italy
Massimo Porta, Italy
Giuseppe Querques, Italy
Guido Ripandelli, Italy
Mario Romano, Italy
Tommaso Rossi, Italy
Andrea Sodi, Italy
Federico Solignani, Italy
Giovanni Staurenghi, Italy
Daniele Tognetto, Italy
Gian Marco Tosi, Italy
Lorenzo Vannozzi, Italy
Monica Varano, Italy
Marco Vecchi, Italy
Silvio Zuccarini, Italy
FLORETINA SUPPORTS:
3
PROGRAM OVERVIEW
Thursday 10
AUDITORIUM
14.30 - 15.30
COMBO CATARACT/VITREORETINAL
SURGERY AND CATARACT
COMPLICATION MANAGEMENT
15.30 - 17.00
DIABETIC MACULAR EDEMA
ROOM VERDE
ROOM LIMONAIA
ROOM ONICE
ROOM 9
ROOM 4
ROOM 5
BAUSCH + LOMB
NSAID treatment in the
prevention of CME: clinical
evidences
OCULAR TRAUMA COURSE
17.00 - 17.30
ROOM 6
ZEISS
Rescan Advanced Wetlab
COFFEE BREAK
17.30 - 18.30
DIABETIC RETINOPATHY
18.30 - 19.30
WELCOME RECEPTION
08.00 - 12.00
LIVE SURGERY
12.00 - 13.00
WORLD SURGICAL RETINA
ESASO
The Future Is Small
ZEISS
Rescan Advanced Wetlab
ZEISS
Rescan Advanced Wetlab
LUNCH
ALLERGAN
Management of DME: the Patient
in Focus
Friday 11
13.00 - 14.00
14.00 - 15.30
ALCON
Beyond cutting speed and
instrument size in vitreoretinal
surgery
DORC
Rethinking Complex Retina
GEUDER
Tamponades: New Generation of
Silicone Oils and Wash-out Liquids
SOOFT
Preservative-free intravitreal
triamcinolone: up to date
SIFI
Diabetic retinopathy: two faces for
a pathology
ZEISS
Rescan Advanced Wetlab
IMAGING AND DIAGNOSTIC
TECHNIQUES
15.30 - 16.45
AMD1
16.45 - 17.00
ITALIAN MASTERS OF RETINA AWARDS
COFFEE BREAK
17.00 - 17.30
17.30 - 18.30
AMD2
08.00 - 12.00
LIVE SURGERY
12.00 - 13.00
RETINAWS
LASER PHOTOCOAGULATION IN
RETINAL DISEASES: NEW
PERSPECTIVE FOR AN OLD
TREATMENT
ALCON
Is there a specific role for NSAIDs
in vitreoretinal surgery?
ALFA INTES
Dyes in Vitreoretinal Surgery
NOVARTIS
Changing the Burden of
Maculopaties: Ten Years of
Experience with Anti-VEGFs
ZEISS
New Horizon in OCT
BAUSCH + LOMB
B+LVitreoretinal approach: New
Trends
OPTIKON
The R-evolution Keeps Going
C.I.O.
Scharioth Macula Lens - SML: a
New Hope for Patients with
Macular Degeneration
MEDONE
Suprachoroidal Surgery: Buckling
and Beyond
ALCON
Ocriplasmin, past, present, future
ADAPTIVE OPTICS IN RETINAL
DISORDERS
ZEISS
Rescan Advanced Wetlab
Saturday 12
LUNCH
13.00 - 14.00
14.00 - 15.00
VITREOMACULAR TRACTION AND
MACULAR HOLE
15.00 - 16.30
MACHINES / INNOVATION / NEW-TECH
Sunday 13
It is Time to Exchange Expertise
and Experience in DME
COFFEE BREAK
16.30 - 16.50
4
SECOND SIGHT
Restoring Hope Through Vision ARGUS II Bionic Eye, 8 Years of
Experience and 150 Patients
Worldwide
POSTERS SESSION - POSTER AREA
16.50 - 18.30
RETINAL DETACHMENT AND PVR
COURSE
08.30 - 09.50
PAPER PRESENTATIONS
SURGICAL SESSION
09.50 - 11.00
MYOPIC MACULOPATHY
PAPER PRESENTATIONS
MEDICAL SESSION
5
THURSDAY DECEMBER 10
MAIN SESSION (14.30-15.30)
MAIN SESSION (15.30-17.00)
AUDITORIUM
Combo cataract/vitreoretinal surgery and cataract complication management
Chairs: Carl Claes, José García-Arumí, Ramin Tadayoni, Kourous A. Rezaei
AUDITORIUM
14.30-14.37
Femtolaser cataract in macular surgery
Stanislao Rizzo
15.30-15.37
14.37-14.44
Diabetic retinal complication after cataract surgery: surgical indication, prevention and management
Donald D’Amico
15.37-15.44
14.44-14.51
Endophthalmitis prophylaxis - differences between US and EU
Stephen G. Schwartz
15.44-15.51
14.51-14.58
New indication in management of post-operative endophthalmitis
Heinrich Heimann
15.58-16.05
14.58-15.05
Multimodal Digitally Assisted Vitrectomy Surgery: The Next Revolution?
Pravin U. Dugel
16.05-16.12
DISCUSSION
15.12-15.30
CASE PRESENTATIONS
Retained lens fragments: standardization in crisis management
Daniele Tognetto
Panel: Carl C. Awh, Steve Charles, Pravin U. Dugel, Claus Eckardt, Carlos Mateo, Virgilio Morales-Canton
SPONSORED COURSES (14.30-15.30)
ROOM ONICE
14.30-15.30
NSAID treatment in the prevention of CME: clinical evidences
Moderators: Rita Mencucci, Gianni Virgili
A company of Valeant Pharmaceuticals International, Inc.
Anti-inflammatory therapy for prevention of post -surgical CME: the missing link
Luigi Fontana
Additive effect of bromfenac over intravitreal injection of anti-VEGF drugs alone in reducing retinal thickness in
neovascular AMD
Maurizio Battaglia Parodi
Questions to experts
ROOM 6
From 14.30
6
Rescan Advanced Wet Lab
Introduction
Ramin Tadayoni, Pasquale De Rosa
16.19-16.26
16.26-16.33
Penetration and persistence of NSAIDs in ocular tissues after topical instillation: profile of an ideal NSAID
Piergiorgio Neri
Real life experience with bromfenac: review of clinical cases
Federico Solignani
16.12-16.19
16.40-17.00
ROOM VERDE
16.00-17.00
DIABETIC MACULAR EDEMA
Chairs: Anat Loewenstein, Sandrine Zweifel
Moderators: Suber Huang, Gian Marco Tosi
Dynamic functionality and static changes of retinal vessels in eyes with diabetic macular edema
Giuseppe Querques
Tailored treatment for DME
Edoardo Midena
DME treatment: established evidence
Pravin Dugel
DISCUSSION
A Comparison of Anti-VEGF agents in the management of diabetic macular edema
Susan Bressler
Relationship between gain in BCVA and changes in OCT retinal thickness in randomized clinical trials of
anti-VEGF therapy for DME
Marco Zarbin
Dexamethasone implant for diabetic macular edema: do pivotal trials hold the promise?
Paolo Lanzetta
Direct comparison of intravitreal ranibizumab and dexamethasone implant for the treatment of
diabetic macular edema in matched eyes of the same patients
Tarek Hassan
Vitrectomy for diabetic macular edema works
Fernando Arévalo
PARALLEL SESSIONS
PARALLEL SESSIONS
THURSDAY DECEMBER 10
DISCUSSION
CASE PRESENTATIONS:
Claudio Panico, Sandrine Zweifel
OCULAR TRAUMA - COURSE
Chair: Carl Claes
Treatment of suprachoroidal haemorrhage
Cesare Forlini
Traumatic IOL subluxation repair
Stratos V. Gotzaridis
25G in trauma
Marco Mura
Approach to eyes with NLP
Marco Zarbin
Surgical techniques
Carl Claes
DISCUSSION
COFFEE BREAK (17.00-17.30)
7
FRIDAY DECEMBER 11
THURSDAY DECEMBER 10
MAIN SESSION (17.30-18.30)
MAIN SESSION (08.00-13.00)
AUDITORIUM
AUDITORIUM
08.00-12.00
17.30-17.37
17.37-17.44
17.44-17.51
17.58-18.05
PARALLEL SESSIONS
18.05-18.12
18.12-18.19
DIABETIC RETINOPATHY
Chair: Susan Bressler
Moderators: Francesco Faraldi, Paolo Carpineto
Early neuroretinal degenerative signs in diabetic retinopathy
Paolo Carpineto
Multimodal investigation of the early pathologic retinal changes in patients with type 1 diabetes mellitus
Monica Varano
The role of anti-VEGF agents in the management of proliferative diabetic retinopathy
Susan Bressler
DISCUSSION
Laser therapy for retinal disease. Does it still make sense?
Thomas Friberg
27 G Bimanual surgery for proliferative diabetic retinal detachment
Martin Charles
Complex PDR cases
André Gomes
DISCUSSION
ROOM ONICE
17.30-18.30
The Future is Small
Chairs: Borja Corcostegui, Francesco Bandello, Giuseppe Guarnaccia
Coordinators: Bruno Falcomatà, Maurizio Battaglia Parodi
New mininvasive vitreous cutters and the cutters of the future
Donald J. D’Amico
The current state of portable vitrectors
Tarek Hassan
27 G vitrectomy techniques
Carl Claes
The fluidics and the exact pressure control during mininvasive vitrectomy
Tommaso Rossi
The thermoinfusion used as a surgical tools
Mario Romano
Mininvasive vitrectomy in paediatric diseases
Antonio Jr. Capone
LIVE SURGERY
Moderators from OR: Kourous Rezaei, David Wong
Moderators from Auditorium: Donald J. D’Amico, Fabio Patelli
Presentations from the auditorium
5 min
OCT-angiography in vitreo-macular interface pathologies
Paolo Carpineto
5 min
ERM surgery and the reasons to limited functional recovery in otherwise successfully operated eyes
André Gomes
5 min
ILM peeling for diabetic macular edema
Donald J. D’Amico
AUDITORIUM
12.00-13.00
WORLD SURGICAL RETINA: global issues and controversies
Chairs: Kourous Rezaei, Ramin Tadayoni
Panel: Andre Gomes, Kazuaki Kadonosono, Manish Nagpal, Kirk Packo
5 min
Telemedicine paradigm for Universal Newborn Screening and surveillance of ROP
Antonio Jr. Capone
VITREOUS FLOATERS TREATMENT
PROS: Pravin U. Dugel
CONS: Joseph Moisseiev
DISCUSSION
Vitrectomy and pharmacology: new and future pharmacological agents for better results
José Garcia-Arumí
DISCUSSION
WELCOME RECEPTION (18.30-19.30)
8
9
FRIDAY DECEMBER 11
FRIDAY DECEMBER 11
ROOM VERDE
13.00-14.00
Management of DME: The Patient in Focus
Chair: Edoardo Midena
ROOM 9
13.00-14.00
Introduction
David Wong
Inflammation in ME
Edoardo Midena
Silicone oils with high molecular weight additives: design concept, laboratory based evidence and results of RCT
David Wong
Why steroids?
Mariacristina Parravano
The choice of silicone oil in real practice: how to select the best option
Mario Romano
Outcome in clinical trials risk vs benefit
Baruch Kuppermann
Experience with F4H5
Antonia Joussen
How to decide - whom to treat with what?
Anat Loewenstein
Heavy silicone oils history, new generation with increased stability, a review
Tomaso Caporossi
PARALLEL SESSIONS
Outcomes in clinical practice
Patricia Udaondo
LIMONAIA
13.00-14.00
Instrument size, cutting speed and beyond in Vitreoretinal Surgery
Moderator: Steve Charles
Speakers: Steve Charles, Carl Claes, Marco Mura, Kirk Packo
DISCUSSION
ROOM 4
13.00-14.00
Our experience with intravitreal preservative-free triamcinolone in diabetic macular edema
Paolo Carpineto
The physics behind small gauge vitreoretinal surgery
Steve Charles
My way with intravitreal preservative-free triamcinolone acetonide
Cesare Forlini
Benefits of 27 Gauge in simple and complex vitreoretinal surgeries:video presentations and panel discussions
Carl Claes, Marco Mura, Kirk Packo
Intravitreal preservative-free triamcinolone acetonide as therapy of non-responder ocular phlogosis
Piergiorgio Neri
Closing Remarks
Steve Charles
Pharmacogenetics as a tool in intravitreal therapy planning
Stefano Piermarocchi
Rethinking Complex Retina
Fernando Arevalo, Francesco Boscia, Fanny Nerinckx, Marco Vecchi
Moderator: Francesco Boscia
Why innovation is critical to retina surgery
Francesco Boscia
Confronting challenging cases
Fanny Nerinckx
EVA: First experiences of a new surgical system
Marco Vecchi
Preservative-free intravitreal triamcinolone: up to date
Chair: Alfonso Giovannini
Moderator: Teresio Avitabile
Intravitreal triamcinolone: from clinical trial to clinical practice
Guido Lesnoni
Introduction - Opening remarks
Steve Charles
ROOM ONICE
13.00-14.00
Tamponades: New generation of silicone oils and wash-out liquids
Chair: David Wong
PARALLEL SESSIONS
LUNCH AND SPONSORED LUNCH SYMPOSIA (13.00-14.00)
Efficacy of a new intravitreal triamcinolone formulation in patients with diabetic macular edema
low-responders to anti-VEGF: clinical and pharmacogenetic aspects
Claudio Panico
ROOM 5
13.00-14.00
Diabetic retinopathy: two faces for a pathology
Conductor: Valentina Bisti - TG1 Journalist
Discussants: Francesco Bandello, Paolo Lanzetta, Massimo Porta
ROOM 6
Full Day
Rescan Advanced Wet Lab
Introduction
Ramin Tadayoni, Pasquale De Rosa
27g - is it a real option for complex cases?
Fernando Arevalo
10
11
FRIDAY DECEMBER 11
FRIDAY DECEMBER 11
MAIN SESSION (14.00-17.00)
15.55-16.02
Anti-VEGF therapy: where did we come from and where are we going to?
Sandrine Zweifel
16.02-16.09
Aflibercept in the treatment of wet-AMD: from pivotal trials to real-life including switching
Paolo Lanzetta
AUDITORIUM
IMAGING AND DIAGNOSTIC TECHNIQUES: Innovations for clinical practice and research
Chairs: Edoardo Midena, Steven D. Schwartz
Moderators: Claudio Azzolini, Lyndon Da Cruz
14.00-14.07
Retina imaging: what is new?
Giovanni Staurenghi
16.09-16.16
Fibrosis and treatment resistance in exudative AMD: the significance of PDGF/VEGF crosstalk
Pravin Dugel
14.07-14-14
En Face OCT
Mario Romano
16.16-16.23
Management of AMD-related CNV with pegaptanib
Maurizio Battaglia Parodi
14.14-14.21
Angio-OCT
Edoardo Midena
14.21-14.28
OCT angiography on diabetic retinopathy
Yuichi Ogura
16.28-16.45
Current treatment, future outcomes and bilateral treatment: debate on AMD evidences
Speakers: Francesco Boscia, Paolo Lanzetta, Anat Loewenstein, Marco Zarbin
14.28-14.35
Adaptive Optics and photoreceptor imaging
Steven D. Schwartz
AUDITORIUM
16.45-17.00
ITALIAN MASTERS OF RETINAL DISEASES AWARDS
Rosario Brancato, Vito De Molfetta, Alessandro Schirru, Mario Stirpe
DISCUSSION
14.41-14.48
OCT in ocular tumors
Cinzia Mazzini
COFFEE BREAK AND SPONSORED COFFEE BREAKS (17.00-17.30)
14.48-14.55
How new imaging methods can aid in the differential diagnosis of intraocular tumours
Heinrich Heimann
ROOM VERDE
Laser photocoagulation in retinal diseases: new perspective for an old treatment
Moderator: Thomas Friberg
14.55-15.02
Chorioretinal Biopsy in the diagnosis and management of complex retinal disease
Lyndon Da Cruz
17.00-17.06
The role of laser treatment for DME in anti-VEGF era
Francesco Boscia
15.02-15.09
Diagnostic and prognostic biopsies of intraocular tumours - improving techniques and treatment
Heinrich Heimann
17.06-17.12
Photostimulation with yellow micropulsed diode laser for macular diseases
Pier Luigi Esposti
DISCUSSION
17.12-17.18
Subthreshold retinal photocoagulation
Paolo Lanzetta
17.18-17.24
Laser treatment in vascular retina diseases
Baruch Kuppermann
15.15-15.30
CASE PRESENTATIONS
Giovanni Staurenghi
AUDITORIUM
AMD 1
Chairs: Ugo Menchini, Marco Zarbin
Moderator: Gianni Virgili
PARALLEL SESSIONS
DISCUSSION
DISCUSSION
LIMONAIA
17.00-17.30
Minimizing macular edema risk in cataract surgery
Moderator: Rita Mencucci
15.30-15.37
Diagnosis and monitoring of AMD, including novel technologies for early detection
Anat Loewenstein
15.37-15.44
Angio OCT in macular degeneration
Alfredo Pece
NSAIDs usage in cataract surgery: high risk patients
Rita Mencucci
15.44-15.51
Genetic Testing for AMD: indications and controversies
Carl C. Awh
Nepafenac 0,1%: unique formulation for preventing macular edema after cataract surgery in diabetic patient
Fabrizio Giansanti
DISCUSSION
12
13
FRIDAY DECEMBER 11
PARALLEL SESSIONS
FRIDAY DECEMBER 11
COFFEE BREAK AND SPONSORED COFFEE BREAKS (17.00-17.30)
MAIN SESSION (17.30-18.30)
ROOM ONICE
17.00-17.30
Dyes in vitreo-retinal surgery
Lutein in chromovitrectomy: biocompatibility and efficacy
Mario Romano
AUDITORIUM
AMD 2
Chairs: Teresio Avitabile, Thomas Friberg
Moderator: Francesco Bandello
Coloring the ILM and ERM with dyes based lutein, trypan blue e brilliant blue
Michele Coppola
17.30-17.37
New perspectives on macular degeneration
Thomas Friberg
Trials on the evaluation of the safety profile of dyes based lutein, trypan blue e brilliant blue: preliminary
Tomaso Caporossi
17.37-17.44
Effect of Chromogranin A-derived Vasostatin-1 on Laser-Induced Choroidal Neovascularization in the Mouse
Francesco Bandello
17.44-17.51
Management of submacular hemorrhage with pars plana vitrectomy and subretinal TPA injection
Remzi Avci
ROOM 4
17.00-17.30
Scharioth Macula Lens - SML - New hope for patients with advanced maculopathy
AMD and treatment options today
SML concept and technology
Patient selection
Pre and Post-op examinations
Surgery
Gabor B. Scharioth
ROOM 5
Suprachoroidal Surgery Techniques
17.00-17.30- Treatment of peripheral detachments and retinal breaks using suprachoroidal buckling
- Treatment of myopic macular detachments
- Future ideas for suprachoridal surgery
Ehab El Rayes
ROOM 9
17.00-17.30
14
The R-evolution keeps going
Tommaso Rossi
DISCUSSION
17.56-18.03
RPE transplantation in macular disease
Lyndon Da Cruz
18.03-18.10
Autologous choroidal transplantation: what have we learned in 10 years?
Grazia Pertile
18.10-18.17
Cell and gene Therapy for Age Related Macular Degeneration
Allen C. Ho
18.17-18.24
Gene therapy for neovascular age-related macular degeneration
Steven D. Schwartz
DISCUSSION
15
SATURDAY DECEMBER 12
SATURDAY DECEMBER 12
AUDITORIUM
08.00-12.00
ROOM ONICE
13.00-14.00
LIVE SURGERY
Moderators from OR: Donald J. D’Amico, Ramin Tadayoni
Moderators from Auditorium: Fabio Patelli, David Wong
25 gauge procedure on a macular hole
Stefano De Cillà
Presentations from the auditorium
Surgery plan strategy on diabetic patient
Michele Coppola
A company of Valeant Pharmaceuticals International, Inc.
5 min
The importance of filters and dyes in the macular surgery
Michele Coppola
5 min
Eye-on-a-chip
David Wong
5 min
Macular pucker surgery
Cesare Mariotti
5 min
The Argus II Retinal Prosthesis
J. Fernando Arevalo
5 min
Electronic retinal implants - the subretinal approach
Robert MacLaren
Bioengineering Argus II
Mark Humayun
AUDITORIUM
RETINAWS
12.00-13.00
Chair: Kourous Rezaei
Panel: Remzi Avci, Martin Charles, Claus Eckardt, Ehab El Rayes, Allen C. Ho, Virgilio Morales-Canton,
Marco Mura, Yuichi Ogura, Kirk Packo
Argus II retinal implant: reaching artificial vision via surgical approach, experience in Italy
Fabio Patelli
The advantages of a combined procedure with Stellaris
Andrea Mercanti
Which is the correct IOL for a patient at vitreoretinal surgery procedure risk?: the opinion of an anterior Surgeon
Vittorio Picardo
ROOM 9
13.00-14.00
ROOM VERDE
13.00-14.00
Changing the burden of maculopaties: ten years of experience with Anti-VEGFs
The pharmacoeconomist perspective
Francesco Saverio Mennini
The physician perspective
Francesco Boscia
Treatment appropriateness: actual scenario and future developments
Claudio Azzolini
LIMONAIA
13.00-14.00
ZEISS AngioPlex™ OCT Angiography: the next generation of vascular imaging
Welcome, topic and speakers introduction
Jean Francois Korobelnik
ZEISS AngioPlex OCT Angiography presentation
Stephanie Magazzeni
Clinical cases, interactive mode
Jean Francois Korobelnik, Francesco Bandello
DISCUSSION
16
Restoring hope through vision - ARGUS II Bionic Eye
8 years of experience and 150 patients worldwide
Chair: Thomas Wolfensberger
Surgical and rehabilitative practice with Argus II retinal prosthesis in the North-East of Italy
Marzio Chizzolini, Francesco Parmeggiani
Argus II implant in dry AMD
Paulo Stanga
LUNCH AND SPONSORED LUNCH SYMPOSIA (13.00-14.00)
PARALLEL SESSIONS
B+L Vitreoretinal approach: new trends
Moderator: Paolo Lanzetta
PARALLEL SESSIONS
MAIN SESSION (08.00-13.00)
Safety, reliability and benefit of the Argus II device
Suber Huang
ROOM 4
13.00-14.00
Journey in VMT from pivotal studies to real-life data
Moderator: Ramin Tadayoni
General introduction
Ramin Tadayoni
VMT epidemiology, ocriplasmin clinical profile and the importance of optimizing early detection and diagnosis
Giovanni Staurenghi
Italian real life clinical cases and key learnings
Francesco Barca
Journey in VMT from pivotal studies to real word data
David Chow
DISCUSSION
17
SATURDAY DECEMBER 12
PARALLEL SESSIONS
SATURDAY DECEMBER 12
ROOM 5
13.00-14.00
ADAPTIVE OPTICS IN RETINAL DISORDERS
Moderator: Andrea Sodi
AUDITORIUM
MACHINES/INNOVATION/NEW-TECH
Chairs: Claus Eckardt, Mark Humayun
Moderators: David Chow, Gisbert Richard
Photoreceptors exploration with Adaptive Optics
Mariacristina Parravano
15.00-15.07
New Instrumentation
David Chow
It is time to exchange expertise and experience in DME
Speakers: Susan Bressler, Edoardo Midena
15.07-15.14
Why Heads-up surgery?
Claus Eckardt
15.14-15.21
Running towards a bionic man
Mark Humayun
15.21-15.28
Retinal prosthesis in Dry-AMD
Paulo Stanga
Ocular Vascular Imaging with Adaptive Optics
Michel Paques
ROOM 6
13.00-14.00
MAIN SESSION (14.00-15.00)
AUDITORIUM
MAIN SESSION (15.00-16.20)
VITREOMACULAR TRACTION AND MACULAR HOLE
Chairs: Ramin Tadayoni, Guido Lesnoni
Moderators: Paolo Arpa, Thomas Wolfensberger
DISCUSSION
14.00-14.07
Structural and vascular intraretinal changes: new classification of vitreo-macular traction
Mario Romano
15.35-15.42
Hydraulic resistance and vitreous chunk length: the quest for ideal cut-rate
Tommaso Rossi
14.07-14.14
Correct case selection in macular hole surgery
André Gomes
15.42-15.49
Surgical innovation: does it benefit the treatment of complex cases?
Mario Romano
14.14-14.21
Ocriplasmin in the real world in 2015 and beyond
Stephen G. Schwartz
15.49-15.56
Improving fluid and air stability with MIVS
Martin Charles
14.21-14.28
Autologous ILM transplant for refractory macular hole not closed after previous ILM peel (Case series)
Thomas Wolfensberger
15.56-16.03
Working under air during vitrectomy. Why and When
Carlos Mateo
14.28-14.35
Face down in macular hole is it still needed
Ehab El Rayes
16.03-16.10
Permanent keratoprosthesis with new approaches with small gauge and medium term perfluorochemical tamponades
Donald J. D’Amico
14.35-14.42
Vitreoretinal interface abnormalities in retinal dystrophies
Andrea Sodi
DISCUSSION
14.47-15.00
18
CASE PRESENTATIONS
George Williams
DISCUSSION
POSTER SESSION AND COFFEE BREAK (16.20-16.50)
POSTER AREA
16.20-16.50
POSTER SESSION
Evaluation panel: Carl Claes, José García-Arumí, Kourous A. Rezaei, Ramin Tadayoni
See pages 24-25
19
SUNDAY DECEMBER 13
SATURDAY DECEMBER 12
MAIN SESSION (16.50-18.30)
PAPER PRESENTATIONS (08.30-09.50)
AUDITORIUM
RETINAL DETACHMENT
Chairs: Carl Claes, José García-Arumí
Moderators: Giorgio Beltrame, Guido Ripandelli
AUDITORIUM
08.30-09.50
ORAL PRESENTATIONS - SURGICAL SESSION
Panel: Martín Charles, Carlos Mateo, Francesco Boscia
See page 22
16.50-16.57
Scleral buckling is the procedure of choice for rhegmatogenous RD in young patients
Joseph Moisseiev
ROOM ONICE
08.30-09.50
16.57-17.04
Chandelier based buckling surgery
Manish Nagpal
ORAL PRESENTATIONS - MEDICAL SESSION
Panel: Sandrine Zweifel, Francesco Faraldi, Marta S. Figueroa, Young-Hee Yoon
See page 23
17.04-17.11
27G and RD (Is it feasible?)
Carl Claes
17.11-17.18
A Rescue Therapy For Persistent Optic Disc Pit Maculopathy In Previously Vitrectomized Eyes
Marta S. Figueroa
17.18-17.25
A safer way to remove proliferative membranes in retinal detachment: PFCL and staining
José García-Arumí
17.25-17.30
Retinal detachment following acute retinal necrosis
Lorenzo Vannozzi
DISCUSSION
AUDITORIUM
17.35-18.30
PVR - COURSE
Chair: José Garcia-Arumì,
Panel: Donald J. D’Amico, Borja Corcóstegui, Kirk Packo, Ramin Tadayoni
MAIN SESSION (09.50-11.00)
AUDITORIUM
09.50-10.00
POSTER AND PAPER PRESENTATIONS AWARD
Best Poster and best Medical and Surgical Presentations Award “Luigi Barca”
AUDITORIUM
MYOPIC MACULOPATHY
Chairs: Francesco Boscia, Carlos Mateo
Moderator: Silvio Zuccarini
10.00-10.07
Anti-VEGF as soon as possible for how long?
Young-Hee Yoon
10.07-10.14
Myopic maculopathy imaging
Alfredo Pece
10.14-10.21
Macular hole surgery in high myopia: comparing techniques
Grazia Pertile
VITRECTOMY VS SCLERAL BUCKLING - DEBATE
PVR from concept to surgical progress
Ramin Tadayoni
10.21-10.28
Scleral buckle and vitrectomy in PVR
Borja Corcóstegui
Minimally invasive vitrectomy for myopic foveoschis
Francesco Boscia
10.28-10.35
Long-term outcomes of 23g vitrectomy with ILM peeling and gas tamponade for myopic traction maculopathy
Marta S. Figueroa
How to manage PVR in trauma cases
José Garcia-Arumì
10.35-10.42
“AMB” macular buckle in retinal detachment and macular hole in high myopia
Cesare Forlini
The role of relaxing retinotomy in PVR
Donald J. D’Amico
10.42-10.49
Myopic Macular Hole. Is it still a challenge?
Carlos Mateo
Endotamponades in PVR
Kirk Packo
10.49-10.56
Suprachoroidal buckles in myopic macular hole
Ehab El Rayes
DISCUSSION
10.56-11.00
DISCUSSION
END OF THE MEETING
20
21
ORAL PRESENTATIONS - SURGICAL SESSION
ORAL PRESENTATIONS - MEDICAL SESSION
S01. EXTRACTION OF AN INTRAOCULAR FOREIGN BODY WITH A NEW FORCEPS
M01. CHARACTERISTICS OF LAMELLAR MACULAR HOLE - ASSOCIATED EPIRETINAL PROLIFERATION
N. ACAR
D. COMPERA, TC KREUTZER, K. KORTÜM, WJ. MAYER, A. WOLF, S. PRIGLINGER, RG. SCHUMANN
S02. MANAGEMENT OF SUB-RETINAL CATARACTOUS LENS MIGRATION WITH GIANT RETINAL TEAR FOLLOWING COMPLICATED
PHACOEMULSIFICATION SURGERY
M02. THE OCRIPLASMIN FOR VITREOMACULAR TRACTION INTRAVITREAL INJECTION DECISIONS (OVIID-I) TRIAL: FULL STUDY RESULTS
S03. VITRECTOMY WITH ARTERIAL SHEATHOTOMY AS A PRIMARY TREATMENT OPTION IN CENTRAL RETINAL ARTERY OCCLUSION
M03. TREATMENT OF CYSTOID MACULAR EDEMA SECONDARY TO COATS DISEASE WITH SLOW –RELEASE DEXAMETHASONE IMPLANT
S04. MACULORRHEXIS OF INTERNAL LIMITING MEMBRANE PEELING SURGERY IN FOVEOSCHISIS CASES
M04. OPTIC DISC-RELATED MACULOPATHY: VITRECTOMY VERSUS CONSERVATIVE MANAGEMENT CASE-CONTROL STUDY.
M. BANSAL, M. KUMAR, A. KUMAR
N. BORSE, V. BORSE
M. HUANG, CL. LEE, WN. LIN, WC. WU
S05. PHACOVITRECTOMY FOR OPEN GLOBE INJURES WITH INTRAOCULAR FOREIGN BODIES AND TRAUMATIC CATARACTS
A. KULIKOV, E. BOIKO, S. CHURASHOV, N. HARITONOVA
S06. IRIS SUTURE TECHNIQUE FOR POSTERIOR LUXED IOL: THE USEFUL AIR SUPPORT
U. LORENZI, E. PARRAT
S07. INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE FOR GIANT MACULAR HOLE SECONDARY TO A RETINAL
VASOPROLIFERATIVE TUMOUR.
U. LORENZI, C. GRONIDIN, R. BENZEKRI, T. GUILLEAUMIE, C. MESNARD, J. VU
S08. TREATMENT OF A COMPLICATED RETINAL DETACHMENT
S. MATTEINI, A. VOLINIA, P TASSINARI, P. FERRI
S09. USE OF SILICONE OIL RETENTION SUTURES IN AN EYE WITH POST-TRAUMATIC COMPLEX RETINAL DETACHMENT,
ANIRIDIA AND APHAKIA
S. MOHAMED, CW. TSANG
S10. MICROSILICONE TUBE ASSISTED SUTURELESS,GLUELESS, SCLERAL FIXATION OF IOL USING 23G MIVS
R. MUKHERJEE
S11. EVALUATION OF INNER RETINAL ADHESION AND MACULAR TRACTION DURING INTERNAL LIMITING MEMBRANE
PEELING IN MYOPIC FOVEOSCHISIS USING INTRAOPERATIVE OPTICAL COHERENCE TOMOGRAPHY IMAGING
D. NAM, V. TAI, H. SEO, M. SEIDER, J. IZATT, C. TOTH
S12. SCLEROUVECTOMY PLUS INTRAOPERATIVE OPHTHALMIC BRACHYTHERAPY FOR IRIS-CILIARY BODY MELANOMAS
M. RELIMPIO LOPEZ, A. GARRIDO HERMOSILLA, F. ESPEJO ARJONA, L. COCA GUTIÉRREZ, M. DÍAZ GRANDA, E. RODRÍGUEZ DE LA RÚA
S13. BILATERAL GIANT RETINAL TEARS IN OSTEOGENESIS IMPERFECTA
P. SCOLLO, M. SNEAD, C. DEVILE
S14. MANAGEMENT OF INTRAOCULAR FOREIGN BODIES
A. VOLINIA, S. MATTEINI, P. TASSINARI, P. PERRI
S15. MODIFIED SEWING SUTURE TECHNIQUE FOR UNEXPECTED CYCLODIALYSIS DURING VITRECTOMY
H. YANG, J. MIN, J. WOO
S16. TREATMENT OF ANTERIOR SEGMENT NEOVASCULARIZATION RELATED TO CHRONIC CIRCUMPHERENTIAL
RHEGMATOGENOUS RETINAL DETACHMENT WITH EXTENSE PERIPHERAL RETINOTOMY
22
S. D’AMELIO
M. FORTUNATO, A. TURTORO
A.GRABOWSKA, J. PATEL, L. DA CRUZ
M05. RETINAL ANGIOMATOUS PROLIFERATION WITH CHORIORETINAL ANASTOMOSIS IN CHILDHOOD COATS DISEASE:
A REAPPRAISAL OF MACULAR FIBROSIS USING MULTIMODAL IMAGING.
A. GROSSO, E. SIGLER, J. CALZADA, C. PANICO, F. FARALDI
M06. CLINICAL CHARACTERISTICS AND VISUAL PROGNOSIS OF ACUTE RETINAL NECROSIS: 10 YEARS SINGLE REFERRAL CENTER EXPERIENCE
D. KIM, JH. YO, JG. KIM
M07. STATIC CHARACTERISTICS AND DYNAMIC FUNCTIONALITY OF RETINAL VESSELS IN PATHOLOGIC MYOPIA
C. LA SPINA, F. CORVI, G. QUERQUES, F. BANDELLO
M08. SYSTEMATIC SCREENING FOR DIABETIC RETINOPATHY: THE FIRST ITALIAN MODEL OF ORGANIZED COLLABORATION
BETWEEN OPHTHALMIC AND DIABETES CENTRES IN A CONTINUING MEDICAL EDUCATION PROGRAMME
P. LANZETTA, F. BOSCIA, E. MANNUCCI, U. MENCHINI, M. PORTA, F. SIMONELLI
M09. OCT ANGIOGRAPHIC FINDINGS OF DIABETIC MACULAR EDEMA AND ITS ASSOCIATION WITH THE RESPONSIVENESS
TO ANTI-VEGF TREATMENTS
YH. YOON, J. LEE, BG. MOON, AR. CHO
M10. HIGHLY FOCUSED EVALUATION OF ATHEROSCLEROTIC RISK PROFILE IN RETINAL THROMBOSIS: VASCULAR EVENTS
INCIDENCE, SEX INVOLVEMENT AND INTERVENTIONAL OUTCOMES ASSESSED BY OPHTHALMOLOGISTS AND
INTERNISTS NETWORK (HEART VISION).
E. PACELLA, F. PACELLA, T. LENZI, M. MECELLA, V. RAPARELLI, M. PROIETTI, L. NAPOLEONE, R. CANGEMI, P. COCCHI, S. BASILI
M11. MACULAR FUNCTION AFTER OCRIPLASMIN TREATMENT: CASE SERIES
S. ROSSI, F. TESTA, P. MELILLO, A. ORRICO, M. DELLA CORTE, F. SIMONELLI
M12. COMPARING REAL WORLD OUTCOMES OF AFLIBERCEPT, RANIBIZUMAB AND OZURDEX IN TREATING RETINAL VEIN OCCLUSION
S. RUFAI, BG. MITCHELL, AS. KARUNATILLEKE, H. ALMUHTASEB, AJ. LOTERY, S. GOVERDHAN
M13. RETINAL MORBIDITY FOLLOWING PHACOEMULSIFICATION AND INTRAOCULAR LENS IMPLANTATION IN EYES WITH
TREATED OR UNTREATED PERIPHERAL RETINAL DEGENERATION
P. SAIKIA
M14. BIOMECHANICAL PROPERTIES OF THE INTERNAL LIMITING MEMBRANE AFTER INTRAVITREAL OCRIPLASMIN TREATMENT
R. SCHUMANN, F. VIELMUTH, V. SPINDLER, A. WOLF, C. HARITOGLOU
L. ZACHARIAS
23
POSTER PRESENTATIONS
P17. EFFICACY AND SAFTY OF SIMULTANEOUS DEXAMETHASONE INTRAVITREAL IMPLANT AND BEVACIZUMAB COMPARED
WITH BEVACIZUMAB MONOTHERAPY FOR BRANCHED RETINAL VEIN OCCLUSION
P01. CAFFEINE EFFECTS ON MICROSURGICAL RETINA PERFORMANCE
P18. WIDE-FIELD OCT ANGIOGRAPHY USING EXTENDED FIELD IMAGING TECHNIQUE TO EVALUATE THE NON-PERFUSION AREA IN RVO
P02. VASCULAR CHANGES IN PRETERM INFANTS: HEART DISEASE AND PULMONARY HYPERTENSION VERSUS PLUS DISEASE
P19. RETINITIS PIGMENTOSA AND PRIMARY VASCULAR DYSREGULATION SYNDROME (FLAMMER SYNDROME)
A. ARRIOLA-LOPEZ, V. MORALES-CANTON
A. ARRIOLA-LOPEZ, V. MORALES-CANTON, M. MARTINEZ-CASTELLANOS
P03. AN UNUSUAL CASE OF BILATERAL COATS-LIKE DISEASE PRESENTING AT A LATER AGE
A. AVUNDUK
P04. CONTRIBUTION OF NEW TECHNOLOGIES IN THE IMAGING OF CHOROIDAL OSTEOMA: SWEPT SOURCE OCT AND ADAPTIVE OPTICS
D. BACHERINI, C. MAZZINI, A SODI
P05. RETINAL EXAMINATION DURING SCLERAL BUCKLING SURGERY USING 20D LENS AND OPERATING MICROSCOPE: A NOVEL TECHNIQUE
M. BANSAL, V. KUMAR, P. CHANDRA, A. KUMAR
P06. RETINAL SCREENING FOR DIABETIC RETINOPATHY USING SMARTPHONE CAMERA AND FUNDUS CAMERA: COMPARATIVE STUDY
M. BANSAL, K. RANGARAJAN, V. KUMAR, P. CHANDRA, A. KUMAR
P07. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS CONCOMITANT TO NEOVASCULAR AGE
RELATED MACULAR DEGENERATION
G. CASALINO, M. UPENDRAN, F. BANDELLO, U. CHAKRAVARTHY
P08. CLINICAL FEATURES AND SURVIVAL OUTCOME OF VITREORETINAL LYMPHOMA
B. CHO, HG. YU
P09. THE POSSIBILITIES OF OPTICAL LASER TECHNOLOGIES IN THE DIAGNOSIS OF RHEGMATOGENOUS RETINAL DETACHMENT
S. CHURASHOV, E. BOIKO, A. YAN, A. ANISIMOV
P10. AN AUTOMATED COMPUTER TABLET-BASED METHOD FOR SELF-TESTING OF NEAR VISUAL ACUITY IN CHILDREN
C. DAL COL, T. ASLAM, J. ASHWORTH, R. HEYES
K. KANG, S. KIM
M. KIMURA, M. NOZAKI, M. YOSHIDA, Y. OGURA
K. KONIECZKA, S. KOCH, A. SCHOETZAU, MG. TODOROVA
P20. PERIPAPILLARY RETINAL NERVE FIBER LAYER AND OPTIC NERVE HEAD CHANGES AFTER PASCAL PAN RETINAL
PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY
M. LOHCHAB, R. VOHRA, Y. SHARMA, P. VENKATESH, T. DADA
P21. OCULAR ISCHEMIC SYNDROME ON THE BACKGROUND OF SEVERE FORM OF IRON DEFICIENCY ANEMIA
D. MAKHKAMOVA
P22. EFFICIENCY OF GLIATILIN IN PATIENTS WITH OCULAR ISCHEMIC SYNDROME
D. MAKHKAMOVA
P23. COMBINING CATARATC SURGERY WITH 25-GAUGE HIGH- SPEED PARS PLANA VITRECTOMY
A. MIELE, A. SAVASTANO, F. FRANCO, L. FINOCCHIO, I. BIAGINI, F. BARCA, S. RIZZO
P24. COMPARATIVE STUDY OF 27-GAUGE VERSUS 25-GAUGE VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT
S. POLIZZI, F. BARCA, T. CAPOROSSI, G. VIRGILI, S. RIZZO
P25. THE ECONOMICS OF COMBINED PHACOVITRECTOMY VERSUS TWO-STEP SURGERY: A DOUBLE-ARMED RETROSPECTIVE CASE SERIES
S. RUFAI, P. ALEXANDER, E. EMSLEY, SC. LASH
P26. “TREAT-AND-EXTEND” DOSING REGIMENS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING
RANIBIZUMAB - WHAT IS THE EVIDENCE? A SYSTEMATIC REVIEW
S. RUFAI, H. ALMUHTASEB, H. LEE, RM.PAUL, BL. STUART, T. KENDRICK, AJ. LOTERY
P27. SUB INNER LIMITING MEMBRANE HEMORRHAGE IN TWO YOUNG PATIENTS: A CLINICAL RIDDLE
A. SAVASTANO, S. RIZZO
P11. I S THERE ANY DIFFRERENCE BETWEEN RANIBIZUMAB AND AFLIBERCEPT INJECTIONS IN TERMS OF INFLAMMATION MEA
SURED WITH ANTERIOR CHAMBER FLARE LEVELS IN AGE-RELATED MACULAR DEGENERATION PATIENTS: A COMPERATIVE STUDY
P28. QUANTITATIVE EVALUATION OF HARD EXUDATES IN DIABETIC MACULAR EDEMA AFTER INTRAVITREAL INJECTI ON
OF STEROID AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
P12. SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE CHOROID IN IDIOPATHIC EPIRETINAL
MEMBRANES BEFORE AND AFTER SURGERY
P29. HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: EFFICACY AND SAFETY
OUTCOMES IN REAL WORLD
S. DEMIREL, S. BILICI, F. BATIOGLU, E. ÖZMERT
F. BARCA, I. BIAGINI, A. SAVASTANO, F. FRANCO, A. MIELE, D. BACHERINI, A. FRANCHINI, G. VIRGILI, S. RIZZO
P13. MASS-SPECTROMETRY FOR DIAGNOSE OF VIRAL UVEITIS
D. FOKINA, A. KULIKOV, D. MALTSEV
P14. RETROSPECTIVE ANALYSIS ON EFFICACY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY OR RESCUE THERAPY
ASSOCIATED WITH LASER TREATMENT IN RETINOPATHY OF PREMATURITY
F. FRANCO, S. FROSINI, A. MIELE, G. VIRGILI, S. RIZZO
P15. NEW PROLIFERATIVE VITREORETINOPATHY SEVERITY SCORING SYSTEM
N. HARITONOVA
P16. VITRECTOMY WITH SIMULTANEOUS INTRAVITREAL INJECTION OF TRIAMCINOLONE VERSUS VITRECTOMY WITH
SIMULTANEOUS INTRAVITREAL DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF PERSISTENT
DIABETIC MACULAR EDEMA
K. KANG, S. KIM
Y. SHIN, S. MOON, H. CHO, E. HONG
F. SOUSA NEVES, J. COSTA, S. FONSECA, L. SILVA
P30. CENTRAL SEROUS CHORIORETINOPATHY SECONDARY LEUPROLIDE ACETATE
G. VECCHIONE
P31. IN VIVO INTRAOCULAR PRESSURE MONITORING DURING MICROINCISION VITRECTOMY WITH OR WITHOUT
INTRAOCULAR ACTIVE CONTROL SYSTEM
H. YANG, J. WOO, J. WOO
P32. GANGLION CELL-INNER PLEXIFORM LAYER AND RETINAL NERVE FIBER LAYER CHANGES IN RETINITIS PIGMENTOSA:
A SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY STUDY
C. YOON, H. YU
P33. OXIDATIVE STRESS AND HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION (RVO) PATIENTS
R. TARTARO, A. GIORNI, M. BECATTI, C. FIORILLO, R. MARCUCCI, G. BRUSCHI, L. MANNINI, A.ALESSANDRELLO LIOTTA, AM. GORI, B. GIUSTI,
D. PRISCO, R. ABBATE, A. SODI, S. RIZZO
P34. EVALUATION OF OUTER RETINA FOLDS IN PATIENTS WITH MACULA OFF RHEGMATOGENOUS RETINAL DETACHMENT
E. PEIRETTI, G. CAMINITI, M.MURA
24
25
EXHIBITORS LIST
26
EXHIBITION FLOORPLAN
ABBOTT MEDICAL OPTICS
A, B
AKTIVE
C2
ALCON
11, 12
ALFA INTES + ALFA INSTRUMENTS + KEMIN PHARMACEUTICA
E
ALLERGAN
19
BAUSCH + LOMB
3, 4
BAYER
2
CALDERARO MEDICAL SERVICE + IRIDEX + NEW TECH + NIDEK + STELOR MEDICA
1, 17, 18
COMPAGNIA ITALIANA OFTALMOLOGICA
P
C.S.O.
16
DORC
5, 6
E. JANACH
F
ESASO
Desk 1
ESPANSIONE GROUP + HAAG-STREIT SURGICAL
13
FARMAPLUS ITALIA
Desk 3
FARMEZ
15
FARMIGEA ITALIA
S
GEUDER AG + CB MEDICAL + FLUORON GmbH
I
INSIGHT INSTRUMENTS, Inc
C3
LEICA MICROSYSTEMS
C
M.S. MEDICAL SERVICE
10
MEDESA
N
MEDICAL BOOKS
Desk 5
MEDONE SURGICAL, Inc
C4
NICOX FARMA
O
NOVARTIS
H, M
OCULUS SURGICAL
20
OFF ITALIA
R
OPTIKON 2000
Desk 4
ORBIS
Desk 2
SECOND SIGHT MEDICAL PRODUCTS
D
SIFI
T
OO GROUP
G
SYNERGETICS ITALIA
7
THEA FARMA
14
VISUFARMA
C1
VITREQ
L
VOLK OPTICAL, Inc
C5
ZEISS
8, 9
27
CONGRESS VENUE
GROUND FLOOR
FLOOR -1, AUDITORIUM
LIMONAIA
MEETING ROOMS
FACULTY LOUNGE
AUDITORIUM
EXHIBITION POSTER
AREA CLOAKROOM
SPEAKERS READY ROOM
REGISTRATION AREA
GARDEN LEVEL, LIMONAIA
FLOOR +2
FLOOR -2, EXHIBITION
Located inside the 18th century Villa Vittoria, Palazzo dei
Congressi boasts a prestigious auditorium which can host
up to 1,000 people. There is also an exhibiting area of 920
sq m, along with other halls which are positioned within
the 4 floors of the villa.
Surrounded by a centuries-old garden, Palazzo dei Congressi and its adjacent Lemon House are located in front
of Palazzo degli Affari and are connected to the Fortezza
da Basso through a pedestrian square, thus forming a
congress & exhibition area which is completely accessible
on foot, in the heart of the city.
The charming interiors of the venue are characterised by
a combination of Florentine antique furniturewith modern and functionally designed halls.
28
29
GENERAL INFORMATION
CONGRESS VENUE
Palazzo dei Congressi
Piazza Adua, 1 - 50100 Florence (Italy)
www.firenzefiera.it
WEBSITE
The official website is www.floretina.it.
LANGUAGE
English is the official language. Simultaneous translations
English/Italiano will be provided during main sessions.
REGISTRATION DESK HOURS
The Registration Desk will be opened as follows:
Thursday 10:
12.30 - 19.00
Friday 11: 07.30 - 19.00
Saturday 12:
07.30 - 19.00
Sunday 13: 08.00 - 11.30
EXHIBITION OPENING HOURS
The Exhibition will be opened as follows:
Thursday 10:
14.00 - 18.30
Friday 11: 08.00 - 18.30
Saturday 12:
08.00 - 18.30
Sunday 13: 08.00 - 12.00
CONGRESS NAME BADGE
Upon registration you will receive your name badge. You are kindly
requested to wear your badge during all sessions and events.
CERTIFICATES OF ATTENDANCE
Certificates of attendance are available from the
registration desks.
INTERNET ACCESSS WiFi
Internet access WiFi is available for congress participants
throughout the public areas.
In order to log in please use the following user name and
password:
Username: floretina2015
Password: floretina2015
30
FLOREtina 2015 APP
Install the FLOREtina 2015 interactive mobile App to your
smartphone and portable devices to access all the Congress
information you could need during and after the Congress:
- See the overview of sessions, speakers and exhibitors
- Create your own program for the event, including
bookmarking the sessions you wish to attend
- Vote during Live Surgery sessions
- Receive real-time updates Download the FLOREtina App
now to enhance your congress experience!
Download available on iTunes and Google Play stores.
BREAKS
Lunch and refreshment breaks are included in the delegate
fee and will be available as follows:
Thursday 10:
Refreshment break
17.00 - 17.30, Exhibition Area
Friday 11:
Refreshment station
09.00 - 12:00, Exhibition Area
Lunch* 13.00 - 14.00, Exhibition Area
+ Lunch Symposia Rooms
Refreshment break
17.00 - 17.30, Exhibition Area
+ Coffee Sessions Rooms
Saturday 12:
Refreshment station
09.00 - 12:00, Exhibition Area
Lunch* 13.00 -14.00, Exhibition Area
+ Lunch Symposia Rooms
Refreshment break
16.20 - 16.50, Exhibition Area
*Tickets to collect the lunch box on Friday and Saturday
are in your congress badge.
SOCIAL EVENTS
Welcome Reception
The Welcome Reception will be held in the
Exhibition Area - Passi Perduti.
Thursday 10, 18.30 - 19.30.
All registered delegates and exhibition visitors are welcome
to attend.
Social Dinner
The Social Dinner will be hosted at Palazzo Borghese.
Friday 11, 20.00 - 23.00.
Admission is by tickets only and must be purchased in
advance. Price €80/person and subject to availability.
CLOAKROOM
A cloakroom is available for participants in the Level -1
close to the Exhibition and the Auditorium.
SPEAKERS READY ROOM
If you are speaking at the meeting, plan time to visit the
Speakers Ready Room to review your presentation. This
space will have an audio-visual tech on site.
The Speaker Ready Room will be located on the Level -2
of the Palazzo Dei Congressi building, known as the PASSI
PERDUTI.
This space is open during the following hours for speakers use:
Thursday 10:
12.30 - 18.30
Friday 11: 07.30 - 18.30
Saturday 12:
07.30 - 18.30
Sunday 13: 08.00 - 11.30
PowerPoint projection is available in all meeting rooms.
For technical reason speakers are not allowed to make
presentations with laptop in the meeting rooms, but must
load their presentation in the Speakers Ready Room.
E.C.M. (Italian attendees only)
Per il Congresso FLOREtina 2015 non è previsto
l’accreditamento residenziale. Per garantire la possibilità
di acquisire i crediti formativi, sarà incluso nella quota
d’iscrizione un programma di formazione a distanza (FAD)
rivolto ai medici.
La piattaforma FAD sarà disponibile a partire dal 1
febbraio 2016 fino al 31 Gennaio 2017 all’indirizzo www.
floretinafad.it.
Ai fini dell’ottenimento dei crediti ECM è necessario:
- Collegarsi al sito ed inserire i propri dati personali
e il proprio indirizzo email usando l’apposito form di
registrazione;
- Validare la propria utenza attraverso un apposito link
ricevuto all’indirizzo email fornito;
- Completare il percorso formativo e compilare tutti i
questionari.
L’attestazione dei crediti è subordinata al superamento del
questionario di valutazione dell’apprendimento con una
percentuale uguale o superiore al 75% di risposte esatte
(numero massimo di 5 tentativi a scalare).
L’attestato ECM, qualora ne ricorrano le condizioni, sarà
scaricabile dall’apposita sezione “crediti ECM” del sito. Si
precisa che per coloro completeranno e supereranno il
percorso formativo nel 2016, l’anno di riferimento per i
crediti sarà il 2016; altrimenti i crediti avranno validità per
l’anno 2017.
MOBILE PHONES
Please do not forget to turn your mobile phones to silent
mode during sessions.
NON-SMOKING POLICY
The FLOREtina Congress is a Non-Smoking event. Delegates
are reminded that smoking in enclosed spaces is illegal in Italy.
LIABILITY AND INSURANCE
The Congress Secretariat and Organizers cannot accept
liability for personal accidents or loss of or damage to
private property of participants. Participants are advised
to take out their own personal travel and health insurance
for their trip.
SAFETY AND SECURITY
Please do not leave bags or suitcases unattended at any
time, whether inside or outside the session halls. Hotels
strongly recommend that you use their safety deposit
boxes for your valuables.
FIRST AID
Should you require first aid assistance, please contact the
registration desk or any uniformed member of the meeting staff.
CITY INFORMATION
Visit www.firenzeturismo.it/en/ for information on
Florence.
31
CURRENCY
Euro (EUR)
All major credit cards (Visa, MasterCard, American Express)
are accepted in most of the restaurants, shops etc.
ELECTRICITY
The electric current supplied is 220 V.
Round, two-pin plug points are available, as elsewhere in
Europe. In case you have any devices from the USA or UK,
please remember to bring a transformer/adapter.
LOCAL HOUR
GMT + 1 hour
USEFUL TELEPHONE NUMBERS IN FLORENCE
- Medical emergency: 118
- Fire emergency: 115
- Police: 113
- Florence airport - information: 055 3061300
- Florence airport - lost luggage: 055 3061302
- For international calls from Italy: 00 + country code + number
- For international calls to Italy: +39 + city code + number
- 24hour Pharmacies:
Santa Maria Novella Station
Via Calzaiuoli, 7 r
Piazza San Giovanni, 20
ACKNOWLEDGEMENTS
DIAMOND
PLATINUM
A company of Valeant Pharmaceuticals International, Inc.
GOLD
BANKING
Most Florence banks open between 08:30 and 13:30
and 14:45 to 15:45 Monday to Friday. They are closed on
weekends and public holidays and most of them have a
cash dispenser and a currency exchange service.
SILVER
TRANSPORTATION
- From the main train station: Firenze S. Maria Novella
is a “main” station located right inside the city centre, in
Piazza della Stazione, and a primary hub in Firenze’s public
transport system. It hosts over 400 trains per day and is
a major intersection point for many bus and taxi lines.
- From the airport: A bus connection (Linea-Volainbus) is
operating from the airport to the city centre (Firenze S.
Maria Novella station) every 20-25 minutes.
- Taxis: Taxis in Florence can be ordered by phone:
+39 055 4242
+39 055 4390
or found at the official taxi stands. You cannot stop a taxi
on the road.
- Bus: Florence has a comprehensive network of local bus
routes. Most of them stop at the main railway station and
therefore near to the convention venue. Bus tickets can
be purchased at most coffee bars and kiosks. Fare is €1,20
multiple trips, valid up to 60 minutes.
- Car parking: There are several paying parking areas
around the Congress Centre.
32
BRONZE
AKTIVE SRL
ALFA INSTRUMENTS SRL
ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE SRL
ANGELINI SPA
BIOFTA-BIODUE SPA
CB MEDICAL SRL
COMPAGNIA ITALIANA OFTALMOLOGICA SCARL
C.S.O. SRL
E. JANACH SRL
FARMAPLUS ITALIA SRL
FLUORON GmbH
GEUDER AG
INSIGHT INSTRUMENTS, Inc
KEMIN PHARMACEUTICA LDA
LEICA MICROSYSTEMS SRL
M.S. MEDICAL SERVICE SRL
MEDONE SURGICAL, Inc
MEDICAL BOOKS
MEDESA SRL
NICOX FARMA SRL
OFF ITALIA SRL
SYNERGETICS ITALIA SRL
TOPCON ITALIA
VISUFARMA SPA
VITREQ
VOLK OPTICAL
33
ORGANIZING SECRETARIAT
AIM Group International - Florence Office
Viale G. Mazzini, 70 - 50132 Florence, Italy
Ph.+39 055 233881 - Fax. +39 055 3906908
[email protected] - www.floretina.it
Scarica

Final Program - FLOREtina 2015